MCOLN1 and cancer: Further investigations into the specific interference of TRPML1 in tumors or CSCs without compromising lysosomal homeostasis in normal cells, alongside the development of potent and selective TRPML1 inhibitors, hold great promise for advancing TRPML1-based approaches in cancer treatment.